Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

NCT04091074 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-03-23

No results posted yet for this study

Summary

patients undergoing carotid stenting take dual anti platelet therapy to prevent thrombotic complications usually used drugs are aspirin plus clopidogrel but there are patients not respond so ticagrelor may be an effective and safe alternative

Conditions

  • Carotid Stenosis

Interventions

DRUG

Ticagrelor

Half of patients undergoing carotid stenting take ticagrelor+aspirin

DRUG

Clopidogrel

Other half ofpatients undergoing carotid stenting take clopidogrel+aspirin

PROCEDURE

Carotid stenting

Patients with carotid stenosis will undergo carotid stenting

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-01
Completion
2022-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091074 on ClinicalTrials.gov